Prediction of Functional Outcome after Myocardial Infarction Using BMIPP and Sestamibi Scintigraphy

Journal of Nuclear Medicine

Volumn 37, Issue 5, 1996, Pages 718-722

  Franken, Philippe R ^a   Dendale, Paul ^a   De Geeter, Frank ^a   Demoor, Doris ^a   Bossuyt, Axel ^a   Block, Pierre ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Fatty acids; Myocardial viability; Technetium 99m sestamibi

Indexed keywords

DIAGNOSTIC AGENT; DOBUTAMINE; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOACTIVE IODINE;

ANGIOCARDIOGRAPHY; ARTICLE; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART; HEART CONTRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PREDICTION AND FORECASTING; SCINTISCANNING; TIME;

CORONARY ANGIOGRAPHY; DOBUTAMINE; ECHOCARDIOGRAPHY; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0030137084     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bolli R, Myocardial stunning in man. Circulation 1992;86:1671-1691.
2. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-415.
3. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
4. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acid for cardiac studies. Eur J Nucl Med 1986;12:S39-S44.
5. Saito S, Yasuda T, Gold UK, et al. Differentiation of regional perfusion and fatty acid uptake in zones of myocardial injury. Nucl Med Commun 1991;12:663-675.
6. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-667.
7. 123I-beta-melhyl iodophenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-291.
8. 201TI to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994;8:47-54.
9. 123[-branched fatty acid: comparison with positron emission tomography. Ann Nucl Med 1993;7(suppl 2):41-47.
10. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotroptc reserve. J Nucl Med 1994;35:1758-1765.
11. 123I radioiodination of 15(p-l-phenyl)-9-methyl pentadecanoic acid, a potential myocardial tracer. Eur J Nucl Med 1987;13:159-160.
12. Ambrose KR, Owen BA, Goodman MM, Knapp FF Jr, Evaluation of the metabolism in rat hearts of two new radioiodinated 3-methyl-branched fatty acid myocardial imaging agents. Eur J Nucl Med 1987;12:486-491.
13. Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analog, iodine-125-15-(p-iodo-phenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818-1822.
14. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogeneous myocardial distribution of iodine-123-15-(p-iodophenyl)-3-R,S-methyl-pentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 1992;19:775-782.
15. Kurata C, Tawarahara K, Taguchi T, et al. Myocardial emission computed tomography with iodine-123-labeled beta methyl branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992;33:6-13.
16. 99mTcsestamibi. Circulation 1994;89:2552-2561.
17. Altehoefer C, vom Dahl J, Biedermann M, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994;35:569-574.
18. Maddahi J, Schelbert H, Brunken R, Di Carli M. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med 1994;35:707-715.
19. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-1031.
20. Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-1531.
21. Sklenar J. Ismail S, Villaneuva FS, Goodman NC, Glasheen WP, Kaul S. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion: an experimental evaluation. Circulation 1994;90:1502-1512.
22. McGillem MJ, DeBoer SF, Friedman HZ, Mancini GBJ. The effects of dobutamine on regional function in the presence of rigid coronary stenoses and subcritical impairments of reactive hyperemia. Am Heart J 1988;115:970-977.